Friday, May 31, 2024
9:30 - 11:30 AM U.S. Central Time
Hyatt Regency McCormick Place, Chicago, IL
July 18-19, 2024
Boston University
In collaboration with Boston University Questrom School of Business and Boston University School of Public Health
Watch this multi-stakeholder public working session held in the European Parliament, Brussels, on achieving healthcare system readiness and capacity for radioligand therapy in Europe.
This webinar discussion looks at current trends in R&D funding, clinical trials, innovation, and other topics related to R&D activity.
Learn about spending and usage of medicines in the past year and outlook to the future, globally and across specific therapy areas and countries.
Discover trends in drug approvals and launches, pipeline activity, and data on clinical trial activity.
Examine the state of the U.S. health system, medicine usage, drug pricing, and costs for patients.
Explore research and development in oncology and the progress being made to improve representativeness of race and ethnicity in clinical trial populations.
Video discussion between Michael Kleinrock, IQVIA Institute, and Craig Burton, Association for Accessible Medicines, on key findings in the IQVIA Institute’s report on Drug Shortages in the U.S. 2023.
Achieving Sustainable Levels of Biosimilar Competition in Europe
Interactions between patient organizations and life sciences companies.